Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinomaOlga Kondrashova, L. Green, Elizabeth Lieschke et al.|Nature Communications|2018Cited by 299
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian CancerDale W. Garsed, Kathryn Alsop, Sián Fereday et al.|Clinical Cancer Research|2017Cited by 95